Literature DB >> 27697243

Intraocular lens exchange surgery at a tertiary referral center: Indications, complications, and visual outcomes.

Emma C Davies1, Roberto Pineda2.   

Abstract

PURPOSE: To identify indications for and visual outcomes of intraocular lens (IOL) exchange to understand recent changes in this surgery.
SETTING: Academic tertiary referral center.
DESIGN: Retrospective case series.
METHODS: Cases were identified by searching the institution's electronic medical records from January 2010 to September 2015 for patients treated by 1 staff physician with the American Medical Association's Current Procedural Terminology code for IOL exchange. These cases were reviewed to determine the surgical indication, type of IOL removed, type of IOL implanted, time between surgeries, surgical complications, and visual outcomes.
RESULTS: The study comprised medical records of 109 eyes. The mean time between the primary cataract surgery and IOL exchange was 1657 days. Dislocation of an in-the-bag posterior chamber IOL (27.5%), intolerance of a multifocal IOL (18.3%), and uveitis-glaucoma-hyphema syndrome (11.9%) were the most frequent indications for IOL exchange. The final IOL position after exchange was most frequently in the capsular bag (43.1%), anterior chamber (25.7%), or sulcus (22%). The final visual acuity at 1 month was 20/40 or better in 78.9% of cases. Of those not achieving this level of acuity, pathology not related to exchange surgery was identified in 48% of cases. The most frequent complications after IOL exchange surgery were posterior capsule opacification (13.8%), cystoid macular edema (10.1%), and high astigmatism (>1.5 diopters) (8.3%).
CONCLUSIONS: The most frequent indication for IOL exchange surgery was dislocated IOLs; the second most frequent indication was patient dissatisfaction after multifocal IOL implantation. The increased ability to place an intracapsular IOL with few intraoperative complications and largely treatable postoperative complications enhances the effectiveness of IOL exchange surgery and patient satisfaction. FINANCIAL DISCLOSURE: Neither author has a financial or proprietary interest in any material or method mentioned.
Copyright © 2016 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27697243     DOI: 10.1016/j.jcrs.2016.06.031

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  6 in total

1.  Intraocular lens explantation in Spain: indications and outcomes at a tertiary referral center from 2010 to 2018.

Authors:  Mª Victoria de Rojas; Sara Viña; Antía Gestoso; Patricia Simón; Marcelino Álvarez
Journal:  Int Ophthalmol       Date:  2019-09-29       Impact factor: 2.031

2.  Visual and Refractive Outcomes Following Exchange of an Opacified Multifocal Intraocular Lens.

Authors:  Stephen A Stewart; Richard N McNeely; Wing C Chan; Jonathan E Moore
Journal:  Clin Ophthalmol       Date:  2022-06-09

3.  Sutureless scleral fixation: comparison between 3-piece IOL and new single-piece foldable IOL.

Authors:  Isabella D'Agostino; Salvatore Parrulli; Stefano De Angelis; Alessandro Invernizzi; Ferdinando Bottoni; Giovanni Staurenghi; Matteo Giuseppe Cereda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-10-22       Impact factor: 3.117

4.  OUTCOMES OF RETROPUPILLARY IRIS CLAW INTRAOCULAR LENS IMPLANTATION COMBINED WITH PARS PLANA VITRECTOMY.

Authors:  Marta Zaleski; Marc Stahel; Roman Eberhard; Robert Alexander Blum; Daniel Barthelmes
Journal:  Retina       Date:  2022-02-17       Impact factor: 3.975

5.  Patients' dissatisfaction with multifocal intraocular lenses managed by exchange with other multifocal lenses of different optical profiles.

Authors:  Olena Al-Shymali; Colm McAlinden; Jorge L Alio Del Barrio; Mario Canto-Cerdan; Jorge L Alio
Journal:  Eye Vis (Lond)       Date:  2022-03-01

6.  Monofocal intraocular lens with enhanced intermediate function as substitute for multifocal intraocular lens in positive dysphotopsia.

Authors:  Tadas Naujokaitis; Ling Zhao; Debora Scharf; Ramin Khoramnia; Gerd U Auffarth
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.